Oncologic Outcomes of a Laparoscopic Right Hemicolectomy for Colon Cancer: Results of a 3-Year Follow-up
Á¶Á¤ÈÆ, ÀÓ´ë·Î, ÇãÇõ, ¹Îº´¼Ò, ¹é½ÂÇõ, ÀÌ°¿µ, ±è³²±Ô,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶Á¤ÈÆ ( Cho Jung-Hoon )
Yonsei University College of Medicine Department of Surgery
ÀÓ´ë·Î ( Lim Dae-Ro )
Yonsei University College of Medicine Department of Surgery
ÇãÇõ ( Hur Hyuk )
Yonsei University College of Medicine Department of Surgery
¹Îº´¼Ò ( Min Byung-Soh )
Yonsei University College of Medicine Department of Surgery
¹é½ÂÇõ ( Baik Seung-Hyuk )
Yonsei University College of Medicine Department of Surgery
ÀÌ°¿µ ( Lee Kang-Young )
Yonsei University College of Medicine Department of Surgery
±è³²±Ô ( Kim Nam-Kyu )
Yonsei University College of Medicine Department of Surgery
KMID : 0356720120280010042
Abstract
Purpose: The purpose of the study is to evaluate the oncologic outcomes of a laparoscopic-assisted right hemicolectomy for the treatment of colon cancer and compare the results with those of previous randomized trials.
Methods: From June 2006, to December 2008, 156 consecutive patients who underwent a laparoscopic right hemicolectomy with a curative intent for colon cancer were evaluated. The clinicopatholgic outcomes and the oncologic outcomes were evaluated retrospectively by using electronic medical records.
Results: There were 84 male patients and 72 female patients. The mean possible length of stay was 7.0 ¡¾ 1.5 days (range, 4 to 12 days). The conversion rate was 3.2%. The total number of complications was 30 (19.2%). Anastomotic leakage was not noted. There was no mortality within 30 days. The 3-year overall survival rate of all stages was 93.3%. The 3-year overall survival rates according to stages were 100% in stage I, 97.3% in stage II, and 84.8% in stage III. The 3-year disease-free survival rate of all stages was 86.1%. The 3-year disease-free survival rates according to stage were 96.2% in stage I, 90.3% in stage II, and 75.6% in stage III. The mean follow-up period was 36.3 (3 to 60) months.
Conclusion: A laparoscopic right hemicolectomy for the treatment of colon cancer is technically feasible and safe to perform in terms of oncologic outcomes. The present data support previously reported randomized trials.
Å°¿öµå
Laparoscopy; Colonic neoplasms; Survival rate
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸